Open access · CC-BY
via OpenAlex
Cellular Senescence Is a Central Driver of Cognitive Disparities in Aging
Matthew P. Baier, Rojina Ranjit, Daniel B. Owen, Jenna L. Wilson, Megan A. Stiles, Anthony M. Masingale, Zachary Thomas, Anne Bredegaard, David M. Sherry, Sreemathi Logan
Aging Cell · 2025 · ▲ 23 citations
Abstract
ABSTRACT Cognitive function in aging is heterogeneous: while some older individuals develop significant impairments and dementia, others remain resilient and retain cognitive function throughout their lifespan. The molecular mechanisms that underlie these divergent cognitive trajectories, however, remain largely unresolved. Here, we utilized a high‐resolution home‐cage‐based cognitive testing paradigm to delineate mechanisms that contribute to age‐related cognitive heterogeneity. We cognitively stratified aged C57Bl/6N male mice by cognitive performance into intact (resilient) or impaired subgroups based on young performance benchmarks. Cognitively impaired males exhibited marked reactive gliosis in the hippocampus, characterized by microglial activation, increased astrocyte arborization, and elevated transcriptional expression of reactivity markers. These changes were accompanied by increased markers of cellular senescence(definition) and the associated senescence‐associated secretory phenotype (SASP) in impaired animals, including p16 INK4a , SASP factors (e.g., Il‐6 , Il‐1b , Mmp3 ), and SA‐β‐gal staining in the hippocampus. Notably, clearance of senescent cells using senolytic agents dasatinib and quercetin ameliorated the heterogeneity in cognitive performance observed with age and attenuated impairment‐associated gliosis, senescence markers, and mitochondrial dysfunction(definition). Aged female mice could not be stratified into subgroups yet showed increased neuroinflammation with age that was not resolved with senolytics(definition). Collectively, our findings implicate cellular senescence as a central driver of sex‐specific neuroinflammation that drives divergent cognitive trajectories in aging. Thus, we demonstrate that senolytic treatment is an effective therapeutic strategy to mitigate cognitive impairment by reducing neuroinflammation and associated metabolic disturbances.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1111/acel.70041
- Canonical
- link ↗
- Fetched
- 2026-11-06 MST
Cite this
APA
Baier, M.P., Ranjit, R., Owen, D.B., Wilson, J.L., Stiles, M.A., Masingale, A.M., Thomas, Z., Bredegaard, A., Sherry, D.M., & Logan, S. (2025). Cellular Senescence Is a Central Driver of Cognitive Disparities in Aging. <em>Aging Cell</em>. https://doi.org/10.1111/acel.70041
Vancouver
Baier MP, Ranjit R, Owen DB, Wilson JL, Stiles MA, Masingale AM, et al. Cellular Senescence Is a Central Driver of Cognitive Disparities in Aging. Aging Cell. 2025. doi:10.1111/acel.70041.
BibTeX
@article{matthew2025Cellul,
title = {Cellular Senescence Is a Central Driver of Cognitive Disparities in Aging},
author = {Matthew P. Baier and Rojina Ranjit and Daniel B. Owen and Jenna L. Wilson and Megan A. Stiles and Anthony M. Masingale and Zachary Thomas and Anne Bredegaard and David M. Sherry and Sreemathi Logan},
journal = {Aging Cell},
year = {2025},
doi = {10.1111/acel.70041},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Circulation 2025
Citation only
Abstract 4366240: Transient pharmacological reprogramming reverses endothelial senescence and promotes vascular regeneration
Stroke 2025
Citation only
Abstract TP35: Age-dependent activation of Cellular Senescence in the Penumbra Contributes to Stroke Injury
Aging Cell 2021
Open access · CC-BY
Whole‐body senescent cell clearance alleviates age‐related brain inflammation and cognitive impairment in mice
Neuroprotection/Neuroprotection (Chichester, England. Print) 2023
Open access · CC-BY
Preserving cognitive function in patients with Alzheimer's disease: The Alzheimer's disease neuroprotection research initiative (ADNRI)
Aging cell 2026
Citation only
Chronic Senolytic Treatment and/or Aerobic Exercise Reduce Senescence and Improve Myocardial Function During Aging in the Heart.
Aging Cell 2026
Open access · CC-BY